Skip to main content

Want a detailed portfolio tracker?

Ventyx Biosciences (VTYX) P/E (2021 - 2026)

Ventyx Biosciences (VTYX) P/E from Dec 31, 2021 to Mar 4, 2026. The TTM Ventyx Biosciences (VTYX) P/E is -9.35. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Ventyx Biosciences (VTYX)

YearP/EChange
2026-9.35+55.04%
2025-6.03+426.23%
2024-1.15+44.23%
2023-0.79-95.80%
2022-18.93-66.39%
2021-56.34N/A

Comparison Ventyx Biosciences (VTYX) P/E with competitors

Ventyx Biosciences (VTYX) P/E is -9.35.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.10-101.09%
ENLVEnlivex Therapeutics Ltd0.15-101.61%
FGENFibroGen Inc0.24-102.57%
TRAWTraws Pharma Inc0.47-105.06%
FBIOFortress Biotech Inc0.71-107.55%
CHRSCoherus Biosciences Inc0.98-110.46%
ORMPOramed Pharmaceuticals Inc1.47-115.76%
AGENAgenus Inc2.05-121.91%
VIVSVivoSim Labs Inc2.54-127.12%
INVAInnoviva Inc3.19-134.10%
CRMDCorMedix Inc3.65-138.99%
ABEOAbeona Therapeutics Inc4.20-144.97%
CVACCureVac N.V.4.45-147.54%
SRPTSarepta Therapeutics Inc4.62-149.45%
GLPGGalapagos NV4.86-151.96%
RIGLRigel Pharmaceuticals4.92-152.61%
ZVRAZevra Therapeutics Inc4.97-153.19%
ABUSArbutus Biopharma Corp5.69-160.89%
CGENCompugen Ltd7.38-178.96%
AUPHAurinia Pharmaceuticals Inc9.25-198.93%
ACADAcadia Pharmaceuticals Inc9.59-202.53%
OMEROmeros Corporation9.88-205.69%
PLXProtalix BioTherapeutics Inc9.91-205.97%
SPROSpero Therapeutics Inc10.73-214.79%
ADMAAdma Biologics Inc11.33-221.17%
SVASinovac Biotech Ltd11.44-222.29%
TBPHTheravance Biopharma Inc11.78-225.94%
HRMYHarmony Biosciences Holdings Inc12.18-230.26%
TGTXTG Therapeutics Inc13.18-240.94%
INCYIncyte Corp13.38-243.10%
SABSSAB Biotherapeutics Inc14.06-250.33%
XOMAXOMA Corp14.95-259.82%
REGNRegeneron Pharmaceuticals Inc14.98-260.20%
PBYIPuma Biotechnology Inc15.05-260.95%
EXELExelixis Inc15.79-268.91%
NAGENiagen Bioscience Inc16.35-274.90%
CPRXCatalyst Pharmaceuticals Inc17.34-285.48%
MDXGMimedx Group Inc17.38-285.81%
ARGXArgen X SE23.07-346.72%
HALOHalozyme Therapeutics Inc23.20-348.10%
XOMAOXOMA Corp25.34-371.03%
VRTXVertex Pharmaceuticals Inc25.66-374.36%
XOMAPXOMA Corp25.67-374.51%
CTMXCytomX Therapeutics Inc25.70-374.81%
ASNDAscendis Pharma A/S26.35-381.83%
RPRXRoyalty Pharma plc - Class A27.50-394.03%
SLNOSoleno Therapeutics Inc29.02-410.28%
LGNDLigand Pharmaceuticals Inc - Class B30.19-422.81%
BMRNBiomarin Pharmaceutical Inc37.51-501.10%
APLSApellis Pharmaceuticals Inc39.02-517.29%
KRYSKrystal Biotech Inc39.70-524.52%
GMABGenmab40.20-529.93%
ONCBeiGene Ltd67.03-816.78%
TECHBio-Techne Corp68.59-833.54%
VCELVericel Corp80.63-962.24%
PHARPharming Group N.V.87.74-1038.28%
ALNYAlnylam Pharmaceuticals Inc124.93-1436.02%
TLXTelix Pharmaceuticals Ltd139.89-1595.97%
CORTCorcept Therapeutics Inc158.39-1793.79%